Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2014

Jul 28, 2014

29745_dirs_2014-07-28_7042aed2-63a0-4a80-add0-79d28ce09f99.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2014-07-25

Reporting Person: Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-07-25 Common Stock S 10000 $63.79 Disposed 87736 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4615 Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $63.72 to $63.84. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.